Compounds > isoalantolactone
Page last updated: 2024-08-25

isoalantolactone and Ovarian Neoplasms

isoalantolactone has been researched along with Ovarian Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Lei, J; Xiao, D; Xie, Z; Xu, J; Yu, J1
Fan, Y; Gao, H; Hu, J; Li, L; Wang, H; Weng, Z1
Bhasin, M; Cordeiro, J; Correa, RG; Czibere, A; Fisher, PB; Gu, X; Li, L; Libermann, TA; Sarkar, D; Simabuco, FM; Tamura, RE; Wang, Y; Zerbini, LF; Zhou, JR1

Other Studies

3 other study(ies) available for isoalantolactone and Ovarian Neoplasms

ArticleYear
Dual regulation of Akt and glutathione caused by isoalantolactone effectively triggers human ovarian cancer cell apoptosis.
    Acta biochimica et biophysica Sinica, 2023, Feb-25, Volume: 55, Issue:1

    Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Female; Glutathione; Humans; Ovarian Neoplasms; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species

2023
Isoalantolactone induces autophagic cell death in SKOV₃ human ovarian carcinoma cells via upregulation of PEA-15.
    Oncology reports, 2016, Volume: 35, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis Regulatory Proteins; Autophagy; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Female; Gene Knockdown Techniques; Humans; Intracellular Signaling Peptides and Proteins; Mice, Inbred C57BL; Ovarian Neoplasms; Phosphoproteins; RNA, Small Interfering; Sesquiterpenes; Transfection; Up-Regulation; Xenograft Model Antitumor Assays

2016
Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy.
    PloS one, 2011, Volume: 6, Issue:9

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Cycle Proteins; Cell Line, Tumor; Diclofenac; Drug Synergism; Enzyme Activation; Female; Gene Expression Regulation, Neoplastic; Humans; Interleukins; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Mice; Mice, SCID; NF-kappa B; Nuclear Proteins; Ovarian Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sesquiterpenes; Sulindac; Tumor Burden; Xenograft Model Antitumor Assays

2011